Polymorphisms in the major histocompatibility complex class 1-like gene known as HFE have been proposed as genetic modifiers of amyotrophic lateral sclerosis (ALS) [1], Alzheimer's disease (AD) [2], Parkinson's disease (PD) [3], and stroke [4]. This evidence concerns the gene HFE and Parkinson disease.